Subject / Started by | Replies / Views | Last post ![]() |
||
---|---|---|---|---|
![]() |
![]() |
1 Replies
55 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
12 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
42 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
116 Views |
![]() by agate |
|
![]() |
![]() |
1 Replies
306 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
355 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
189 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
257 Views |
![]() by agate |
|
![]() |
![]() |
Subcutaneous Ocrevus gets EU approval
Started by agate |
1 Replies
297 Views |
![]() by agate |
![]() |
![]() |
0 Replies
245 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
214 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
227 Views |
![]() by agate |
|
![]() |
![]() |
(JAMA) Rituximab vs ocrelizumab in RRMS
Started by agate |
4 Replies
2976 Views |
![]() by agate |
![]() |
![]() |
0 Replies
294 Views |
![]() by agate |
|
![]() |
![]() |
3 Replies
457 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
205 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
120 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
149 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
193 Views |
![]() by agate |
|
![]() |
![]() |
0 Replies
200 Views |
![]() by agate |
Normal Topic
Hot Topic (More than 15 replies)
Very Hot Topic (More than 1 replies)
Locked Topic
Sticky Topic
Poll